CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors

Journal:

Journal of Clinical Investigation

Published:

2025-06-06

DOI:

10.1172/jci189920

Affiliations:

9

Authors:

16

Go to article

Institutions	Authors	Share
City of Hope, United States of America (USA)	7.666667	0.48
Chongqing International Institute for Immunology, China	7.000000	0.44
Xiangya Hospital, CSU, China	0.333333	0.02
Vanderbilt University Medical Center (VUMC), United States of America (USA)	0.333333	0.02
UCI Chao Family Comprehensive Cancer Center, United States of America (USA)	0.333333	0.02
University of California, Irvine (UCI), United States of America (USA)	0.333333	0.02

Interested in Oncology and Carcinogenesis?